Related references
Note: Only part of the references are listed.Association of Vitamin D Deficiency with Diabetic Nephropathy
So-hyeon Hong et al.
ENDOCRINOLOGY AND METABOLISM (2021)
Vitamin D deficiency 2.0: an update on the current status worldwide
Karin Amrein et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2020)
Association between serum 25-hydroxyvitamin D and diabetic kidney disease in Chinese patients with type 2 diabetes
Shaofeng Xie et al.
PLOS ONE (2019)
The effects of vitamin D3 supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: A randomized double blind placebo controlled clinical trial
A. Esfandiari et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus
Marian Sue Kirkman et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Update of pathophysiology and management of diabetic kidney disease
Yi-Chih Lin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System
Domenico Santoro et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Vitamin D deficiency increases the risk of retinopathy in Chinese patients with Type 2 diabetes
R. He et al.
DIABETIC MEDICINE (2014)
Vitamin D Prevents Podocyte Injury via Regulation of Macrophage M1/M2 Phenotype in Diabetic Nephropathy Rats
Xiao-Liang Zhang et al.
ENDOCRINOLOGY (2014)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Vitamin D Receptor Signaling in Podocytes Protects against Diabetic Nephropathy
Youli Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes
Giuseppe Penno et al.
JOURNAL OF HYPERTENSION (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
Dick de Zeeuw et al.
LANCET (2010)
High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria
Hiroyuki Ito et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Association of Proteinuria with Race, Cause of Chronic Kidney Disease, and Glomerular Filtration Rate in the Chronic Kidney Disease in Children Study
Craig S. Wong et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The Association of Vitamin D Deficiency and Insufficiency with Diabetic Nephropathy: Implications for Health Disparities
Vanessa A. Diaz et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2009)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Z. Zhang et al.
KIDNEY INTERNATIONAL (2008)
The pathogenesis of diabetic nephropathy
Suma Dronavalli et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Noncalcemic actions of vitamin D receptor ligands
S Nagpal et al.
ENDOCRINE REVIEWS (2005)
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
D de Zeeuw et al.
CIRCULATION (2004)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)